Search our Innovation Portfolio

MeMed BV® is the first FDA-cleared and CE-Marked host-immune response assay for accurately distinguishing bacterial and viral infections in just 15 minutes in children and adults.
MeMed BV’s performance has been validated in multi-national, blinded clinical studies and real world settings enrolling >20,000 subjects in Europe, Israel and the United States. These studies consistently demonstrated high performance across settings, ages, and syndromes.
MeMed Key® is a compact platform that runs highly sensitive protein measurements that previously could only be done on large, expensive lab equipment. Together, MeMed Key and BV help physicians make better decisions when managing acute infections.

CardMedic is an award-winning app and digital platform that empowers healthcare staff to communicate instantly with patients facing language barriers, low health literacy, or sensory impairments. It bridges critical service gaps by providing pre-written clinical dialogues in 50+ languages, sign language, Easy Read, and read-aloud formats, alongside instant access to accredited live interpreters. This reduces delays, errors, and reliance on ad-hoc solutions. Used across NHS Trusts and US health systems, CardMedic enables rapid deployment of digital and in-person language services, improving patient safety, engagement, and outcomes while enhancing efficiency, reducing costs, and streamlining healthcare workflows.

Designed to combat stigma and ease NHS strain, InsideOut, empowers individuals to take control of their mental health 24/7. Using AI-based assessments, InsideOut integrates health data to generate a Whole-Self Wellbeing Score (patent pending). The Wellbeing score is used to guide users to highly-personalised clinical interventions. Users can access 24/7 conversational support from Remi™, AI coach, alongside digital therapeutic courses, including CBT and mindfulness. Courses are delivered by AI Avatars optimising accessibility and affordaiblity. Clinical programmes boost engagement, while optional human therapy ensures a stepped-care model.